In Vitro-Derived Alternatively Activated Macrophages Reduce Colonic Inflammation in Mice

Gastroenterology

Volumn 138, Issue 4, 2010, Pages 1395-1405

  Hunter, Meaghan M ^a   Wang, Arthur ^b   Parhar, Kuljit S ^b   Johnston, Michael J G ^b   Van Rooijen, Nico ^c   Beck, Paul L ^b   McKay, Derek M ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Crohn's Disease; Helminth; Hymenolepis; Interleukin 10

Indexed keywords

CD205 ANTIGEN; CD68 ANTIGEN; CLODRONIC ACID; DINITROBENZENE SULFONIC ACID; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; LYMPHOCYTE ANTIGEN; MITOGENIC AGENT; MYELOPEROXIDASE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ALTERNATIVELY ACTIVATED MACROPHAGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL STIMULATION; CELL TRANSFER; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME ACTIVITY; HISTOLOGY; HUMAN; HUMAN CELL; HYMENOLEPIS DIMINUTA; IN VITRO STUDY; IN VIVO STUDY; INJECTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SPLEEN CELL;

EID: 77950259565     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.12.041     Document Type: Article

References (40)

1. McKay D.M. The therapeutic helminth?. Trends Parasitol 25 (2009) 109-114
2. Maizels R.M., Balic A., Gomez-Escobar N., et al. Helminth parasites-masters of regulation. Immunol Rev 201 (2004) 89-116
3. Hayes K.S., Bancroft A.J., and Grencis R.K. Immune-mediated regulation of chronic intestinal nematode infection. Immunol Rev 201 (2004) 75-88
4. Wilson M.S., Taylor M.D., Balic A., et al. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 202 (2005) 1199-1212
5. Smith P., Mangan N.E., Walsh C.M., et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 178 (2007) 4557-4566
6. Summers R.W., Elliott D.E., Urban Jr. J.F., et al. Trichuris suis therapy in Crohn's disease. Gut 54 (2005) 87-90
7. Summers R.W., Elliott D.E., Urban Jr. J.F., et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128 (2005) 825-832
8. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 3 (2003) 23-35
9. Loke P., MacDonald A.S., Robb A., et al. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur J Immunol 30 (2000) 2669-2678
10. Kreider T., Anthony R.M., Urban Jr. J.F., et al. Alternatively activated macrophages in helminth infections. Curr Opin Immunol 19 (2007) 448-453
11. Reyes J.L., and Terrazas L.I. The divergent roles of alternatively activated macrophages in helminthic infections. Parasite Immunol 29 (2007) 609-619
12. Loke P., Nair M.G., Parkinson J., et al. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol 3 (2002) 7-14
13. Nair M.G., Gallagher I.J., Taylor M.D., et al. Chitinase and Fizz family members are a generalized feature of nematode infection with selective up-regulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun 73 (2005) 385-394
14. Hunter M.M., Wang A., Hirota C.L., et al. Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically-induced colitis. J Immunol 174 (2005) 7368-7375
15. Persaud R., Wang A., Reardon C., et al. Characterization of the immuno-regulatory response to the tapeworm Hymenolepis diminuta in the non-permissive mouse host. Int J Parasitol 37 (2007) 393-403
16. Wang Y., Wang Y.P., Zheng G., et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 72 (2007) 290-299
17. Anthony R.M., Urban Jr. J.F., Alem F., et al. Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med 12 (2006) 955-960
18. Van Rooijen N., and Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174 (1994) 83-93
19. Kühl A.A., Kakirman H., Janotta M., et al. Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 133 (2007) 1882-1892
20. + regulatory T-cells during recovery from colitis via Fas-FasL induced death. J Immunol 180 (2008) 8316-8326
21. McKay D.M., Croitoru K., and Perdue M.H. T-cell monocyte interactions regulate epithelial physiology in a co-culture model of inflammation. Am J Physiol Cell Physiol 270 (1996) C418-C428
22. Qualls J.E., Kaplan A.M., van Rooijen N., et al. Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukoc Biol 80 (2006) 802-815
23. Mohr E., Serre K., Manz R.A., et al. Dendritic cells and monocytes/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature. J Immunol 182 (2009) 2113-2123
24. Zhao A., Urban Jr. J.F., Anthony R.M., et al. Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 135 (2008) 217-225
25. + T cells to be sustained during chronic infection. J Immunol 179 (2007) 3926-3936
26. Raes G., Van den Bergh R., De Baetselier P., et al. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J Immunol 174 (2005) 6561-6562
27. + regulatory T cells. Nat Immunol 4 (2003) 330-336
28. Coombes J.L., Robinson N.J., Maloy K.J., et al. Regulatory T cells and intestinal homeostasis. Immunol Rev 204 (2005) 184-194
29. Couper K.N., Blount D.G., and Riley E.M. IL-10: the master regulator of immunity to infection. J Immunol 180 (2008) 5771-5777
30. Kamada N., Hisamatsu T., Okamoto S., et al. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol 175 (2005) 6900-6908
31. Rogler G., Andus T., Aschenbrenner E., et al. Alterations of the phenotype of colonic macrophages in inflammatory bowel disease. Eur J Gastroenterol Hepatol 9 (1997) 893-899
32. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5 (2005) 953-964
33. Rodriguez-Sosa M., Satoskar A.R., Calderon R., et al. Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability. Infect Immun 70 (2002) 3656-3664
34. Schnoeller C., Rausch S., Pillai S., et al. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol 180 (2008) 4265-4272
35. Brem-Exner B.G., Sattler C., Hutchinson J.A., et al. Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol 180 (2008) 335-349
36. Toyokawa H., Nakao A., Bailey R.J., et al. Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl 14 (2008) 346-357
37. Weber M.S., Prod'homme T., Youssef S., et al. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat Med 13 (2007) 935-943
38. Izcue A., Coombes J.L., and Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 212 (2006) 256-271
39. Hunter M.M., Wang A., and McKay D.M. Helminth infection enhances disease in a murine TH2 model of colitis. Gastroenterology 132 (2007) 1320-1330
40. Elliott D.E., Summers R.W., and Weinstock J.V. Helminths as governors of immune-mediated inflammation. Int J Parasitol 37 (2007) 457-464